Thera-Gesic

Quick links to important sections

Thera-Gesic

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Thera-Gesic

Property Description
Active Ingredient Methyl Salicylate and Menthol
Form Topical Cream or Ointment
Pharmacological Class Topical Analgesic / Counter-irritant
Common Use Localized relief from the sensation of minor aches and pains
Origin Semi-synthetic (derived from natural components like wintergreen oil)

Thera-Gesic is an over-the-counter (OTC) combination product formulated as a topical dosage form intended to provide temporary, localized relief from the sensation of minor aches and pains. The product is categorized as a Topical Analgesic and a Counter-irritant, relying on external application to create a sensory distraction on the skin's surface. Thera-Gesic is specifically known for its non-greasy cream formulation, a key differentiating factor over traditional, heavier ointments.


What Type of Medicine is Thera-Gesic?

Thera-Gesic is formally classified as a Counter-irritant, a category of non-prescription medications intended for external use only. This classification establishes that the medication is designed to provide relief locally rather than achieving systemic effects throughout the body. Within this class, ingredients like methyl salicylate function through nerve stimulation to manage localized discomfort. This type of medicine is clinically recognized for delivering temporary relief directly where the discomfort is felt.


What is Thera-Gesic Made of and How is it Formulated?

Thera-Gesic is a combination product whose primary active ingredients are Methyl Salicylate and Menthol, typically presented as either a cream or an ointment. Methyl Salicylate, chemically a salicylate ester and known commonly as oil of wintergreen, provides the product’s rubefacient (warming) property. This component is integrated with Menthol, a cyclic monoterpene alcohol, to create a distinct dual sensory effect. These rubefacients create sensory input in the applied area; the chemical properties of the ingredients are harnessed to produce a physical sensation that helps distract from the underlying discomfort.

Regulatory References

  1. NIH MedlinePlus Review

What side effects are possible with Thera-Gesic?

Possible Side Effects and Safety Information

This section outlines the adverse reactions and safety considerations for topical methyl salicylate and menthol products, as documented in government regulatory sources, such as the U.S. Food and Drug Administration (FDA) labeling.

Documented Adverse Reactions

Adverse effects are primarily local, affecting the Skin and Subcutaneous Tissue Disorders (dermatological). Regulatory documents indicate that certain reactions require immediate discontinuation.

Primary Adverse Reaction Management Requirement
Skin irritation or redness Requires discontinuation if excessive
Mild burning sensation May be temporary upon application

Serious Adverse Reactions

The official labeling documents the potential for rare but serious systemic events, typically associated with excessive exposure or absorption due to the methyl salicylate component.

  • Signs of Allergic Reaction: Severe hypersensitivity reactions can occur, including rash, hives, or swelling of the face, lips, tongue, or throat, or difficulty breathing.
  • Systemic Salicylate Toxicity (Salicylism): Excessive absorption can lead to symptoms like ringing in the ears (tinnitus), severe dizziness, and vomiting.
  • Gastrointestinal Events: Potential for serious issues like a bleeding ulcer, with warning signs including bloody, black, or tarry stools.

Population-Specific and Administration Constraints

Regulatory documents define specific usage limitations:

  • Pediatric Use: Safety has not been established for use in children under 12 years of age.
  • Pregnancy and Breast-feeding: Individuals must consult a health professional prior to use.
  • Application Site Restrictions: The product must not be applied to wounds, damaged, broken, or irritated skin.
  • Contraindication with Heat: The product must not be used with a heating pad, tight bandaging, or immediately after a hot shower or bath, as this can increase systemic absorption.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for Thera-Gesic, a topical combination product containing Methyl Salicylate and Menthol, is focused primarily on the risk of systemic salicylate toxicity (salicylism) resulting from accidental ingestion or excessive topical absorption.

Documented Overdose Manifestations and Risks

Overdose manifestations, as documented in regulatory sources, include characteristic signs such as tinnitus (ringing in the ears), nausea, vomiting, and dizziness. More severe, life-threatening outcomes can include metabolic acidosis, profound CNS effects (e.g., seizures or coma), respiratory failure, and acute renal failure.

Ingestion of even a small amount of the methyl salicylate component is specifically noted in regulatory guidance as potentially life-threatening in children.

Required Emergency Actions

The official labeling mandates that any suspected overdose or accidental ingestion requires immediate action. Seek immediate medical help right away, or contact a Poison Control Center immediately for instruction. Urgent medical evaluation is necessary upon the onset of symptoms indicative of systemic toxicity, such as persistent vomiting, confusion, or severe breathing changes.

Management and Antidote Status

Overdose management is symptomatic and supportive. Treatment procedures may involve urinary alkalinisation or hemodialysis for severe toxicity. No specific antidote is known for salicylate poisoning.

Therapeutic Uses of Thera-Gesic

What Thera-Gesic Treats: Main Uses and Benefits

Thera-Gesic is commonly used to help with the symptomatic management of minor aches and pains arising from muscles and joints. This topical support is applicable across domains where additional symptomatic support is needed, and is commonly used in conditions that may include simple backache, muscle strains, sprains, arthritis, and common bruises.

The cream may be part of symptomatic management in situations involving minor soft-tissue trauma and muscle soreness following physical overexertion, such as after a strenuous workout or heavy lifting. It generally assists with easing the overall burden of symptoms, offering symptomatic relief that helps patients cope more steadily with temporary, localized discomfort.

“Topical analgesics may be considered relevant tools when short-term symptomatic assistance is needed for minor musculoskeletal symptoms.”

Quick Fact: Relief for Muscle and Joint Discomfort

This product may be relevant for managing symptoms that interfere with daily comfort and is commonly used across conditions characterized by episodic or fluctuating manifestations, rather than persistent, complex pain.

Regulatory References

  1. National Library of Medicine DailyMed listing

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Thera-Gesic — Official Regulatory Information

The eligibility profile for Thera-Gesic (Methyl Salicylate and Menthol topical) is strictly defined by government regulatory documents, focusing on age, allergy status, and physical condition.


Eligibility Scope

Category Regulatory Status
Populations Allowed Adults and children 12 years of age and older are eligible for self-medication [Source: FDA DailyMed Label].
Contraindicated Populations Individuals with a known hypersensitivity or allergy to methyl salicylate, menthol, aspirin, or other salicylates [Source: DailyMed, Regulatory Safety Data].
Age-Related Restriction Children under 12 years of age must consult a doctor prior to use, as safety has not been established. Children under 2 require physician consultation.
Conditional Use Status Individuals who are pregnant or breast-feeding must ask a health professional before use [Source: DailyMed].
Physical Restriction Use is prohibited on wounds or damaged skin [Source: DailyMed].

Eligibility Structure Summary

Official documents define eligibility by age threshold, prohibiting unsupervised use in children under 12 years and establishing absolute contraindications based on allergy status to salicylates. Pregnancy and lactation require conditional use following consultation. These rules ensure that only individuals without documented hypersensitivities who are 12 and older are eligible for use under standard OTC conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for this topical combination product is based on the systemic absorption of its active metabolite, salicylate, and the potential for additive effects or increased exposure documented in regulatory labeling.


Drug-Drug and Pharmacodynamic Interactions

Interaction Entity Official Interaction Classification
Oral Anticoagulants (e.g., Warfarin) Pharmacodynamic Reinforcement: Potential for increased risk of bleeding due to the antiplatelet/anticoagulant effects of absorbed salicylate.
Oral Salicylate Analgesics (e.g., Aspirin) Additive Systemic Burden: Risk of increased total systemic salicylate concentration, which may lead to toxicity (salicylism).

Exposure-Related Restrictions and Timing Rules

Co-use with external physical conditions that increase absorption is restricted. The official profile classifies the following as interaction-related restrictions:

  • Exposure Modifiers: The use of heating pads, external heat, or tight bandaging is prohibited. These conditions act as pharmacokinetic modifiers and increase the rate and extent of systemic absorption.
  • Timing Restriction: A mandatory rule states the product must not be applied immediately before or after showering or bathing.

Population-Specific Interaction Notes

Regulatory documents include an interaction-related note for use during the third trimester of pregnancy. This is due to the systemic risk of absorbed salicylate potentially causing premature closure of the fetal ductus arteriosus.

Mechanism of Action

Sensory Receptor Modulation (Neurological Masking)

This mechanism involves the menthol component acting as an agonist on the Transient Receptor Potential Melastatin 8 ( TRPM8) receptor, a cold-sensitive ion channel on peripheral nerve endings. This binding creates a thermal signal that rapidly modulates the transmission of other signals originating from the area, resulting in an alteration of afferent nerve signal processing.


Local Prostaglandin Synthesis Inhibition

The second mechanism is driven by the absorbed methyl salicylate, which acts as an inhibitor of Cyclooxygenase (COX) enzymes within the underlying tissue. This action reduces the formation of prostaglandins, which are chemical mediators that typically enhance nerve sensitivity. The resulting decrease in pro-signaling molecules contributes to a reduction in the chemical sensitization of peripheral nerve fibers, contributing to a more prolonged local modulation of nerve signal activity.


Peripheral Dual-Pathway Modulation

The drug operates through the combined effect of sensory nerve agonism and biochemical enzyme inhibition, focusing its activity strictly on the peripheral and cutaneous systems. This approach allows for concurrent modulation of afferent nerve signaling and down-regulation of inflammatory mediator production, resulting in a dual-mechanism influence on local sensory pathways.

Dosage and Administration Information

Administration Scope

Feature Official Labeled Guideline
Route of administration Topical (External use only).
Dosing regimen Apply a thin layer into and around the painful area. The dose is adjusted by the user: one layer for a mild effect, two thin layers for strong, and three thin layers for a very strong effect.
Frequency and limits Application is repeated not more than 3 to 4 times daily for adults and children 12 years of age and older.
Preparation and handling The product must be rubbed in gently until thoroughly absorbed. Hands must be washed thoroughly after application, unless the hands are the area being treated.
Age-group rules The standard regimen applies to Adults and children 12 years of age and older. Use in children younger than 12 years requires determination by a doctor.
Duration limit Stop use if the condition persists for more than 7 days or if symptoms clear up and occur again within a few days.

Official Use Protocol

Thera-Gesic is a topical external analgesic whose administration is defined by frequency and duration constraints. The use protocol is limited to as-needed (PRN) application, with the maximum frequency set at three to four times in a 24-hour period. Dosage is controlled through the number of thin layers applied, allowing for titration of the applied amount based on the desired strength of action. This usage pattern is defined as a short-term intervention, with official instructions requiring discontinuation if the need for continuous application exceeds seven days.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Thera-Gesic

Evidence for Temporary Relief of General Minor Musculoskeletal Aches

Evidence for topical analgesics like Thera-Gesic is found within the regulatory process itself. Governmental health authorities, such as the FDA, conducted extensive regulatory reviews to evaluate if the active ingredients, Methyl Salicylate and Menthol, could be Generally Recognized as Safe and Effective (GRASE) for sale as non-prescription drugs. This process was applied in studies examining patient-reported experiences and historical use data for ingredients recognized as external counter-irritants. The resulting regulatory finding concluded that the available data met the criteria for general public use.

This evidence is intended to cover temporary, localized application for conditions where symptoms may vary in intensity, such as simple backache or strains. However, this regulatory evidence does not provide individual predictions for every specific type of discomfort. Comparative evidence is lacking to show how this combination performs against every other class of topical treatment.

Evidence for Pain Associated with Muscle Strain

Research has specifically explored the use of this combination in conditions involving periods of heightened symptoms, particularly localized mild to moderate muscle strain. Short-term, controlled intervention studies, such as Randomized Controlled Trials (RCTs), were conducted during periods of increased symptom activity in adult patients (18 years and older).

The research examined outcomes related to physical discomfort, including measurements of pain intensity changes and localized changes in pain sensitivity. Findings describe patterns observed in the studies where pain relief measurements were recorded as different between the active application and the inactive placebo application during the study period. The follow-up durations for these studies were limited, typically observing responses over defined time intervals of 8 to 12 hours.

What is Still Uncertain About Thera-Gesic Research

Long-term effects are not fully established because research focusing on extended use is not the primary basis for the OTC classification. Additionally, few data are available for certain special populations, such as children under 12 or patients with multiple existing health conditions. Peer-reviewed systematic reviews have noted that for topical counter-irritants as a class, the evidence quality varies across studies, and overall certainty remains low, indicating that research is ongoing to fully characterize these effects.

Key Studies & References

  1. Over-the-Counter Drug Monograph: United States Food and Drug Administration Approach (Summary of the GRASE review process for OTC drugs)
  2. THERA-GESIC ® Creme (Official FDA/DailyMed Labeling information for use, warnings, and ingredients)

Frequently Asked Questions (FAQ)

Common questions about Thera-Gesic (FAQ)

Q: What is the active ingredient in Thera-Gesic?

A: According to the official product information, the primary active ingredients in Thera-Gesic are Methyl Salicylate and Menthol. This combination is responsible for the localized effects of the topical product.

Q: Are there different strengths or types of Thera-Gesic cream?

A: Thera-Gesic is generally formulated as a cream or ointment. Official product information indicates that the strength of the effect is managed by the user, who may apply one, two, or three thin layers for increasing levels of action.

Q: Why is Thera-Gesic sometimes called a 'counterirritant'?

A: Thera-Gesic is formally classified as a counter-irritant by government health authorities. This term describes that the product is designed to provide local relief by creating a sensory distraction on the skin's surface, which helps manage localized discomfort.

Q: Why is Thera-Gesic available without a prescription?

A: Thera-Gesic is an over-the-counter (OTC) product because government health authorities conducted regulatory reviews of its active ingredients. The available data met the criteria for the product to be Generally Recognized as Safe and Effective (GRASE) for non-prescription sale under specific use conditions.

Q: What are the ingredients that make Thera-Gesic feel hot or cold?

A: The product has a dual sensory effect. The menthol component acts on cold-sensitive receptors to create a cooling sensation, while the methyl salicylate provides the warming or 'rubefacient' property.

Q: Does Thera-Gesic cause a burning or cooling sensation?

A: Official information confirms that Thera-Gesic creates a dual sensory effect because of its two active ingredients. Menthol causes a cooling sensation, and methyl salicylate provides a warming sensation. The label indicates that if excessive redness or a mild burning sensation occurs, use should be stopped.

Q: Is it normal to feel a strong warmth after applying Thera-Gesic?

A: The methyl salicylate component provides an intended warming property called a rubefacient effect. However, the label indicates that if excessive skin irritation, redness, or a mild burning sensation occurs, the product's use should be stopped.

Q: How quickly does Thera-Gesic usually start to work?

A: The menthol component acts on cold-sensitive receptors on peripheral nerve endings, creating a thermal signal. This mechanism is described as rapidly modulating the transmission of other nerve signals in the applied area.

Q: How long can I expect the feeling from Thera-Gesic to last?

A: Official information from the regulatory review process is based on studies that typically observed pain relief responses over defined time intervals. These timeframes were generally recorded as responses over 8 to 12 hours.

Q: What is the difference in how Thera-Gesic works compared to an oral pill?

A: Thera-Gesic is a topical product whose activity is strictly focused on the peripheral and cutaneous systems (the skin and underlying tissue). Unlike an oral pill, it works by modulating local sensory pathways in the area of application rather than achieving widespread systemic effects throughout the entire body.

Q: Is Thera-Gesic meant to treat the cause of the pain or just the feeling of it?

A: As a counter-irritant, Thera-Gesic is designed to provide temporary, localized relief from the sensation of minor aches and pains. Its dual mechanism works by modulating nerve signaling and down-regulating inflammatory mediators in the local area.

Q: Can Thera-Gesic be used for joint pain, or is it only for muscle aches?

A: Regulatory evidence covers temporary, localized application for general minor musculoskeletal aches. This category can include both muscle discomfort and joint discomfort, but the label does not provide specific predictions for every type of discomfort.

Q: Is there any research on using Thera-Gesic for back pain?

A: The regulatory evidence covers temporary, localized application for conditions where symptoms may vary in intensity, such as simple backache or strains. The evidence base supports its use for minor musculoskeletal aches.

Q: Can Thera-Gesic be used for nerve pain, such as sciatica?

A: The regulatory evidence covers general minor musculoskeletal aches, and it does not provide specific guidance on the use for the diagnosis of nerve pain or sciatica.

Q: What is the typical age range of people who use Thera-Gesic?

A: The product is intended for adults and children 12 years of age and older. Official information states that safety has not been established for use in children under 12 years of age.

Q: Do people typically use Thera-Gesic for chronic pain or only acute pain?

A: The official use protocol defines the usage pattern as a short-term intervention. Instructions require use to be discontinued if the condition persists for more than seven days.

Q: Is there a limit to how many days in a row someone can use Thera-Gesic?

A: Yes, regulatory documents define the product's use as a short-term intervention. The official protocol states that use must be stopped if the condition persists for more than 7 days.

Q: Is it possible to develop an allergy or sensitivity to Thera-Gesic over time?

A: Official labeling documents the potential for rare but serious systemic events, including the risk of severe hypersensitivity reactions (allergic reaction). The product information indicates that if symptoms of allergy develop, use should be discontinued.

Q: What happens if Thera-Gesic gets on areas other than where the pain is?

A: The product is strictly for topical external use. If it causes excessive skin irritation or redness in areas outside the target application site, or anywhere else, the official labeling states that use should be discontinued.

Q: Can Thera-Gesic be used on the face or near the eyes?

A: The product information prohibits use on damaged or irritated skin, and adverse effects are primarily local dermatological disorders. Application should be limited to the intended area.

Q: Why do some people report no effect from Thera-Gesic?

A: Regulatory information acknowledges that for topical counter-irritants as a class, the evidence quality varies across studies, and overall certainty remains low. This indicates that individual responses to the product may differ.

Q: Can Thera-Gesic interact with blood thinner medication?

A: Official labeling documents a potential for pharmacodynamic reinforcement with oral anticoagulants, such as Warfarin. This interaction may increase the risk of bleeding.

Q: Are there any known issues with using Thera-Gesic alongside oral pain relievers?

A: Official labeling only documents a risk of additive systemic burden when used with oral salicylate analgesics (like Aspirin). This is due to the potential for increased total systemic salicylate concentration in the body.

Q: Do the ingredients in Thera-Gesic get absorbed into the bloodstream?

A: The product's interaction profile is based on the systemic absorption of its active metabolite, salicylate. This absorption forms the basis for interaction warnings, such as those concerning oral anticoagulants.

Q: Why does the label mention not covering the area tightly after application?

A: Regulatory documents prohibit tight bandaging because it acts as a pharmacokinetic modifier. This means that tight covering increases the rate and extent of the drug's systemic absorption, which can increase the risk of adverse effects.

Q: Can I put clothes on immediately after applying Thera-Gesic?

A: Official regulatory documents prohibit tight bandaging of the application area, as this increases systemic absorption. The prohibition on tight bandaging is based on its risk of increasing systemic absorption.

Q: Does Thera-Gesic work better if massaged deeply into the skin?

A: The official preparation and handling instructions do not suggest deep massage. They state that the product must be rubbed in gently until thoroughly absorbed, and hands must be washed after application.

Q: Can Thera-Gesic be used with a heating pad or ice pack?

A: Co-use of the product with a heating pad or external heat is prohibited by regulatory documents, as this can increase systemic absorption. Use with an ice pack is not addressed in official regulatory warnings.

Q: Is it possible to use too much Thera-Gesic?

A: Yes. The official use protocol defines maximum frequency and duration limits because excessive exposure or absorption can lead to serious systemic events. This includes a risk of Systemic Salicylate Toxicity, or Salicylism.

How should Thera-Gesic be stored and disposed of?

How to Store and Dispose of Thera-Gesic

The storage and disposal of Thera-Gesic Cream must align strictly with official regulatory requirements to ensure product integrity and public safety.

Official Storage Conditions

Thera-Gesic must be stored at controlled room temperature, maintaining a range between 20 C and 25 C (68 F and 77 F). The product must be kept from freezing and should be stored out of the reach of children to prevent accidental ingestion. The container should not be used if the tube is punctured.

Disposal Instructions

Expired or unused cream should be discarded safely. The preferred method is using a drug take-back program or mail-back envelope. If these options are unavailable, the medicine can be disposed of in the household trash after being mixed with an undesirable substance, such as dirt or used coffee grounds, and sealed in a leak-proof container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Thera-Gesic found in:

A-Z Index: